Crispr Therapeutics Ag - Common Shares (CRSP)'s 30-day implied volatility (IV30) was 56.9% at the close on November 2, 2026, up from 44.5% the day before, against a 52-week range of 44.1% to 74.6%. Its 20-day historical volatility was 59.8%.
Data as of November 2, 2026.